Multiclinic study of norfloxacin for treatment of urinary tract infections
- 26 June 1987
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 82 (6) , 53-58
- https://doi.org/10.1016/0002-9343(87)90619-x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infectionsAntimicrobial Agents and Chemotherapy, 1985
- Norfloxacin disposition after sequentially increasing oral dosesAntimicrobial Agents and Chemotherapy, 1983
- Antibacterial activity of norfloxacinAntimicrobial Agents and Chemotherapy, 1983
- Susceptibility of clinical isolates of Staphylococcus saprophyticus to fifteen commonly used antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1982
- In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprimAntimicrobial Agents and Chemotherapy, 1982
- Comparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolatesAntimicrobial Agents and Chemotherapy, 1982
- In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1982
- In vitro antibacterial activity of norfloxacin (MK-0366)Antimicrobial Agents and Chemotherapy, 1982
- Comparison of the antibacterial activity of norfloxacin (MK 0366, AM 715), a new organic acid, with that of other orally absorbed chemotherapeutic agentsInfection, 1982
- In Vitro Antibacterial Activity of AM-715, a New Nalidixic Acid AnalogAntimicrobial Agents and Chemotherapy, 1980